1. Apolipoproteins: New players in cancers
    Yingcheng He et al, 2022, Frontiers in Pharmacology CrossRef
  2. Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery
    Chen Chen et al, 2022, BMC Cancer CrossRef
  3. Preoperative Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio Can Predict Prognosis in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study
    Junhong Li et al, 2022, Current Oncology CrossRef
  4. Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma
    Fiona O’Connell et al, 2023, Cancers CrossRef
  5. Therapeutic role of biogenic silver and gold nanoparticles against a DMH-induced colon cancer model
    Rani Mata et al, 2023, Biomaterials Advances CrossRef
  6. The tangled web of dyslipidemia and cancer: Is there any association?
    Kiyan Heshmat-Ghahdarijani et al, 2022, Journal of Research in Medical Sciences CrossRef
  7. Post-treatment serum triglyceride: An effective biomarker for body fat mass and overall survival in esophageal squamous cell cancer patients treated with chemoradiotherapy
    Jiahua Lyu et al, 2022, Frontiers in Nutrition CrossRef
  8. Post‐diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis
    Nerea Becerra‐Tomás et al, 2024, International Journal of Cancer CrossRef